Inspire Medical Systems (INSP)
NYSE:INSP
Want to see INSP full AI Analyst Report?
INSP Stock Chart & Stats
$57.59
-$1.46(-0.68%)
At close: 4:00 PM EST
$57.59
-$1.46(-0.68%)
Day’s Range― - ―
52-Week Range$48.30 - $163.35
Previous CloseN/A
Volume95.34K
Average Volume (3M)939.07K
Market Cap
$1.58B
Enterprise Value$1.32B
Total Cash (Recent Filing)$308.27M
Total Debt (Recent Filing)$62.15M
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Aug 04, 2026EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.02
Shares Outstanding28,797,306
10 Day Avg. Volume992,654
30 Day Avg. Volume939,068
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)3.47
Price to Sales (P/S)2.97
P/FCF Ratio34.52
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue1.45
Enterprise Value/Gross Profit1.70
Enterprise Value/Ebitda18.91
Forecast
1Y Price Target
$55.42Price Target Upside-3.77% Downside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)1.86
Revenue Forecast (FY)$961.88M
Bulls Say, Bears Say
Bulls Say
Guidance ResilienceAnalyst notes company guidance remains intact because financial estimates did not assume a material reimbursement uplift from the coding change, which limits downside to near-term forecasts as coding and billing practices stabilize.
Profitability And ValuationAnalyst highlights that the company has demonstrated positive profitability and trades at a low revenue multiple, so a device replacement cycle could drive further margin expansion.
Reimbursement MappingCMS mapped the new procedure codes to the same hospital payment category as the existing therapy, preserving hospital reimbursement for the Inspire V procedure and reducing the risk of a sustained revenue-per-procedure decline.
Bears Say
Physician Reimbursement UncertaintyUncertainty about physician reimbursement persists because a payment reduction tied to a billing modifier has not been clarified, leaving regional payment outcomes unclear and potentially reducing physician incentives.
Regulatory Coding DecisionMedicare's coding and payment reversal eliminated an anticipated pricing tailwind by removing obstructive sleep apnea as a covered diagnosis for a CPT code, creating regulatory and reimbursement uncertainty that undercuts revenue upside.
Utilization And Growth RiskProcedure denials and unclear reimbursement could reduce patient utilization and slow the activation of new treatment centers, prompting management to lower the revenue outlook and making valuation harder to justify.
Inspire Medical Systems News
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $48.30 and its highest was $163.35 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Inspire Medical Systems’s market cap is $1.58B.
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is Aug 04, 2026 which is in 89 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on May 04, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.275 by $0.375.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Overvalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is -0.24.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 28,797,306 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.275. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Currently, no hedge funds are holding shares in INSP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inspire Medical Systems Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$55.42 (-3.77% Downside)
$55.42 (-3.77% Downside)
Blogger Sentiment
Bullish
INSP Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 822.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Bearish
Bullish news 33%
Bearish news 67%
Bearish news 67%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.66%
12-Months-Change
Fundamentals
Return on Equity
17.98%
Trailing 12-Months
Asset Growth
24.71%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
INSP Company Deck
INSP Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Balanced/Neutral — The company delivered modest revenue growth, margin expansion, stronger operating cash flow, a solid cash position, and meaningful clinical progress, but faces material near-term headwinds from coding and reimbursement uncertainty and the WISER pilot that prompted a significant revenue guide reduction and short-term profitability pressure. Management outlined actions to mitigate the disruption (education, field reimbursement hiring, inventory strategy, targeted investments) and expects improvement later in 2026, while a permanent coding solution (new CPT) is not expected until 2028.View all INSP earnings summariesINSP Revenue Breakdown
97.02% U.S.
2.98% Other
INSP Stock 12 Month Forecast
Average Price Target
$55.42
▼(-3.77% Downside)
Technical Analysis
Integer Holdings
―
LivaNova
―
Irhythm Technologies
―
TransMedics Group
―
PROCEPT BioRobotics
―
Ownership Overview
1.70% Insiders
33.41% Mutual Funds
3.61% Other Institutional Investors
31.11% Public Companies and
Individual Investors